GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (LTS:0IL8) » Definitions » Short Interest

FibroGen (LTS:0IL8) Short Interest


View and export this data going back to 2018. Start your Free Trial

What is FibroGen Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of FibroGen's Short Interest

For the Biotechnology subindustry, FibroGen's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FibroGen's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroGen's Short Interest distribution charts can be found below:

* The bar in red indicates where FibroGen's Short Interest falls into.



FibroGen (LTS:0IL8) Business Description

Traded in Other Exchanges
Address
409 Illinois Street, San Francisco, CA, USA, 94158
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

FibroGen (LTS:0IL8) Headlines

No Headlines